Characteristics | Etanercept (n = 12) | Adalimumab (n = 7) |
---|---|---|
Sex | ||
Men, No (%) | 4 (33) | 1 (14) |
Women, No (%) | 8 (67) | 6 (86) |
Age (years), mean (SD) | 60 (7) | 53 (12) |
Disease duration (years), mean (SD) | 13 (6) | 10 (7) |
DMARDs before TNFα blocker (n), mean (SD) | 5 (2) | 5 (3) |
Previous DMARDs (n) | ||
Methotrexate | 12 | 7 |
Hydroxychloroquine | 5 | 4 |
Sulfasalazine | 5 | 6 |
Ciclosporin A | 5 | 2 |
Gold (intramuscular) | 4 | 1 |
Gold (oral) | 4 | 2 |
Leflunomide | 6 | 5 |
Azathioprine | 1 | 0 |